Multicenter Retrospective Registry of Anterior Communicating Artery Aneurysms With Endovascular Therapy (MACAARET)

May 14, 2015 updated by: Federico Zarco, Hospital Clinic of Barcelona

Based on the anatomical features of the anterior Communicating artery complex, the investigators will analyze the outcome of the ACoA aneurysms treated by endovascular therapy.

The most common site of intracranial aneurysms is the anterior communicating artery (AcomA). AcomA aneurysms account for approximately one-fourth of all intracranial aneurysms.

Recent publications have addressed specifically the endovascular treatment of AcoA aneurysms. Furthermore, detailed anatomic characteristics and the effects of the multiple variations of the anterior communicating artery complex have scarcely been reported.

The hemodynamic factors play a fundamental role in the adequate treatment of aneurismal coiling.

The objective of our registry is to analyze the impact of morphological configuration of the anterior communicating artery complex and the results of coil embolization in AcoA aneurysms

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Spain
      • Barcelona, Spain, 08036
        • Recruiting
        • Hospital Clinic
        • Contact:
        • Contact:
          • Federico
        • Principal Investigator:
          • Federico Zarco, MD
        • Principal Investigator:
          • Antonio Lopez Rueda, MD
        • Sub-Investigator:
          • Juan Macho Fernandez, MD
        • Sub-Investigator:
          • Fernando Delgado, MD
        • Sub-Investigator:
          • Alejandro González García, MD
        • Sub-Investigator:
          • Mariano Werner, MD
        • Sub-Investigator:
          • Oscar Chirife, MD
        • Sub-Investigator:
          • Napoleón Macias, MD
        • Sub-Investigator:
          • Luis San Roman, MD
        • Sub-Investigator:
          • Jordi Blasco, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with Communicating Artery Aneurysm treated with endovascular coiling.

Description

Inclusion Criteria:

  • Patient with Anterior Communicating Artery Aneurysm treated with endovascular coiling.

Exclusion Criteria:

  • Patients without imaging follow up of at least 12 months after endovascular treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Effective Aneurysm Coiling (no residual cerebral aneurysm)
Time Frame: 1 year
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All Cause Mortality
Time Frame: 1 year
1 year
Neurological Outcome (classified with the Glasgow Outcome Scale, Rankin Scale)
Time Frame: 1 year
All patients will be classified with the Glasgow Outcome Scale, Rankin Scale.
1 year
Procedural device-related serious adverse events
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospital Clinic of Barcelona

Collaborators

Hospital Universitario Reina Sofia de Cordoba
Hospitales Universitarios Virgen del Rocío

Investigators

  • Principal Investigator: Federico Zarco, MD, Hospital Clinic of Barcelona

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2015

Primary Completion (ANTICIPATED)

June 1, 2017

Study Completion (ANTICIPATED)

December 1, 2017

Study Registration Dates

First Submitted

May 12, 2015

First Submitted That Met QC Criteria

May 14, 2015

First Posted (ESTIMATE)

May 15, 2015

Study Record Updates

Last Update Posted (ESTIMATE)

May 15, 2015

Last Update Submitted That Met QC Criteria

May 14, 2015

Last Verified

May 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NeurovascCDI001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Aneurysm

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe